LND topic: covid page 65

covid

What We Really Miss About Face-to-Face Chats

November 6, 2024

Ever wondered what people truly miss about face-to-face talks when digital devices take over? It's not just about seeing each other's faces on a screen. During the COVID-19 pandemic, when in-person meets were hard to come by, people had to rely more on texts, calls, and social media to stay connecte

health

COVID-19 Vaccine Trust in America: A Consistent Story

November 5, 2024

From 2021 to 2023, the United States saw a consistent level of skepticism toward the science behind COVID-19 vaccines, with about a third of the population hesitant. Despite minor fluctuations, this mistrust persisted. Men, university graduates, and higher-income individuals were more likely to trus

business

TGI Fridays’ Bankruptcy: A Struggle for Survival

November 2, 2024

In a surprising turn of events, TGI Fridays, the iconic restaurant chain, has filed for bankruptcy protection. This move comes after the company faced a series of setbacks, including the closure of numerous branches across the United States. The primary cause for this financial struggle, according t

business

Why TGI Fridays is Seeking Bankruptcy Help

November 2, 2024

The iconic restaurant chain TGI Fridays has sought bankruptcy protection. This move comes after the company faced significant financial struggles due to the COVID-19 pandemic and its capital structure. The Dallas-based chain filed for Chapter 11 bankruptcy in a Texas federal court on Saturday. The

health

COVID Vaccines Banned: A Unique Decision in Idaho

November 1, 2024

In a surprising move, a public health department in Idaho has been barred from giving COVID-19 vaccines. This is the first time in the US that a health department has been halted from providing these vital shots. While other states have limited vaccine promotion or recommended against them, Idaho's

business

Pfizer's Surprising Q3 Win: Paxlovid and Vaccines Boost Sales

October 30, 2024

Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pres

business

Pfizer's COVID-19 Meds Boost Sales: What's Next?

October 30, 2024

Pfizer's third-quarter earnings just came in, and guess what? They're way better than expected! The company's making a lot more money, thanks to a big demand for their COVID-19 treatments. Their best-selling drug, Paxlovid, brought in a whopping $2. 7 billion in the third quarter alone. This is a ma

health

Older Adults and Immunocompromised Advised to Get Extra COVID Shots

October 27, 2024

The Centers for Disease Control and Prevention (CDC) has some new advice for older adults and people with weakened immune systems. It’s all about getting an extra dose of the COVID-19 vaccine to stay safe. If you’re 65 or older, or if your immune system isn’t as strong, the CDC says to get a second

politics

Delayed Vote on Trump Advisor's Censure: Politics or Academic Freedom?

October 26, 2024

A recent vote by Stanford's Faculty Senate to decide whether to lift the censure on Scott Atlas, a COVID-19 adviser to former President Trump, has been delayed. The Senate wants to avoid any political interpretations, especially with the 2024 elections coming up. This delay seems to be a way to stee

business

Miami's Private School Pinch: A Hedge Fund Mogul's Dilemma

October 26, 2024

Ken Griffin, the billionaire boss of Citadel, is facing a unique challenge as he moves his hedge fund from Chicago to Miami. You might think the main issue is the cost of relocating, but insiders say it's something else. Miami's private schools are struggling to keep up with the influx of wealthy fa